Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
22.30
-1.07 (-4.58%)
At close: Mar 20, 2026, 4:00 PM EDT
22.63
+0.33 (1.48%)
After-hours: Mar 20, 2026, 5:07 PM EDT
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.28 billion as of March 20, 2026. Its market cap has increased by 321.02% in one year.
Market Cap
1.28B
Enterprise Value
937.29M
1-Year Change
321.02%
Ranking
Category
Stock Price
$22.30
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.28B, an increase of 89.09%. That is a compound annual growth rate of 52.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.28B | -34.36% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 1.37B |
| Biohaven | 1.37B |
| MBX Biosciences | 1.36B |
| Ardelyx | 1.36B |
| Palvella Therapeutics | 1.35B |
| Vir Biotechnology | 1.30B |
| Immatics | 1.30B |
| AtaiBeckley | 1.29B |